Savio, M.; Ferraresi, A.; Corpina, C.; Vandenberghe, S.; Scarlata, C.; Sottile, V.; Morini, L.; Garavaglia, B.; Isidoro, C.; Stivala, L.A.
Resveratrol and Its Analogue 4,4′-Dihydroxy-trans-stilbene Inhibit Lewis Lung Carcinoma Growth In Vivo through Apoptosis, Autophagy and Modulation of the Tumour Microenvironment in a Murine Model. Biomedicines 2022, 10, 1784.
https://doi.org/10.3390/biomedicines10081784
AMA Style
Savio M, Ferraresi A, Corpina C, Vandenberghe S, Scarlata C, Sottile V, Morini L, Garavaglia B, Isidoro C, Stivala LA.
Resveratrol and Its Analogue 4,4′-Dihydroxy-trans-stilbene Inhibit Lewis Lung Carcinoma Growth In Vivo through Apoptosis, Autophagy and Modulation of the Tumour Microenvironment in a Murine Model. Biomedicines. 2022; 10(8):1784.
https://doi.org/10.3390/biomedicines10081784
Chicago/Turabian Style
Savio, Monica, Alessandra Ferraresi, Chiara Corpina, Sara Vandenberghe, Chiara Scarlata, Virginie Sottile, Luca Morini, Beatrice Garavaglia, Ciro Isidoro, and Lucia Anna Stivala.
2022. "Resveratrol and Its Analogue 4,4′-Dihydroxy-trans-stilbene Inhibit Lewis Lung Carcinoma Growth In Vivo through Apoptosis, Autophagy and Modulation of the Tumour Microenvironment in a Murine Model" Biomedicines 10, no. 8: 1784.
https://doi.org/10.3390/biomedicines10081784
APA Style
Savio, M., Ferraresi, A., Corpina, C., Vandenberghe, S., Scarlata, C., Sottile, V., Morini, L., Garavaglia, B., Isidoro, C., & Stivala, L. A.
(2022). Resveratrol and Its Analogue 4,4′-Dihydroxy-trans-stilbene Inhibit Lewis Lung Carcinoma Growth In Vivo through Apoptosis, Autophagy and Modulation of the Tumour Microenvironment in a Murine Model. Biomedicines, 10(8), 1784.
https://doi.org/10.3390/biomedicines10081784